ECM Weekly (8 November 2020) - Ant, Sunac Svcs, Jinke Svcs, Antengene, Gland Pharma, Kalyan Jewel
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
303 Views
Eisai: Shares Surge on Positive Review of Drug Candidate; Blockbuster Potential if Approved
Biogen and Eisai have collaborated on the development and commercialisation of Aducanumab, an investigational treatment for Alzheimer’s disease....
388 Views
JD Health Pre-IPO: Peer Comparison Reveals JD Health’s Financials Are Stronger than Competition
This insight compares and contrasts the business models of JD Health vs its competitors Ping An Health and Ali Health. Our analysis reveals that JD...
468 Views
China Healthcare Weekly (Oct.30)
This article summarized major industry viewpoints, companies news and capital market review in healthcare industry in China during the week of Oct.30.
238 Views
JD Health: Looking Beyond the Obvious
This Insight provides an in-depth view of JD Health in the context of a "penetration story" with a focus on the market opportunity to inform...
416 Views